{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:23Z","timestamp":1794330263691,"version":"4.9.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Evidence suggests a link between gut microbiota and diabetes mellitus, yet the specific role in diabetic peripheral neuropathy (DPN) remains elusive. The study aims to explore the association through Mendelian randomization and 16S rRNA gene sequencing analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Mendelian randomization (MR) analysis was employed to investigate the causal association between gut microbiota and diabetic neuropathy. Diabetes mellitus (DM) and DPN mice models were developed via high-fat diet (HFD) feeding followed by intraperitoneal streptozotocin (STZ) administration at 30 mg\/kg (DM group) or 60 mg\/kg (DPN group). The occurrence of diabetic neuropathy was determined by evaluating pain-related behavioral parameters in mice. Additionally, fecal samples from mice and patients with diabetic neuropathy were collected, and 16S rRNA sequencing was performed to analyze the composition of gut microbiota.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mendelian randomization analysis identified 14 gut microbiota species exhibiting a causal relationship with diabetic neuropathy. In animal studies, diabetic neuropathy mice exhibited decreased mechanical pain thresholds and reduced thermal withdrawal latency. Sequencing analyses further revealed significant alterations in gut microbiota composition in both DPN mice and DPN patients compared to control group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study integrates Mendelian randomization analysis with 16S rRNA fecal assessments from animal models and clinical patients, revealing that gut microbiota imbalances may contribute to diabetic neuropathy development and providing novel insights for its prevention and therapeutic strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1632406","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:17:45Z","timestamp":1758773865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Causal relationship between gut microbiota and diabetic neuropathy: a Mendelian randomization and 16S rRNA sequencing analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Yingqing","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panwei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingbang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00188-0","article-title":"Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments","volume":"21","author":"Elafros","year":"2022","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"Mbanya JC et\u00a0al: IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ejphar.2018.06.034","article-title":"Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets","volume":"833","author":"Dewanjee","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41582-024-01041-y","article-title":"The global and regional burden of diabetic peripheral neuropathy","volume":"21","author":"Savelieff","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.29.9.1021","article-title":"Caraway DL et\u00a0al: Health care resource utilization and costs in patients with painful diabetic neuropathy treated with 10 kHz spinal cord stimulation therapy","volume":"29","author":"Taylor","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00617","article-title":"Lyu X et\u00a0al: Prevalence of and Risk Factors for Peripheral Neuropathy in Chinese Patients With Diabetes: A Multicenter Cross-Sectional Study","volume":"9","author":"Pan","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.cmet.2023.06.010","article-title":"Yu L et\u00a0al: Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2023.05.003","article-title":"New perspectives in diabetic neuropathy","volume":"111","author":"Eid","year":"2023","journal-title":"Neuron"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325753","article-title":"Le Roy T et\u00a0al: Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism","volume":"71","author":"Belda","year":"2022","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e34870","DOI":"10.1016\/j.heliyon.2024.e34870","article-title":"Solanesol alleviates CFA-induced chronic inflammatory pain via inhibition of proinflammatory cytokines in spinal glial cells","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"Yamada T et\u00a0al: A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12998\/wjcc.v12.i1.1","article-title":"Gut-targeted therapies for type 2 diabetes mellitus: A review","volume":"12","author":"Xu","year":"2024","journal-title":"World J Clin cases"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0203223","DOI":"10.1128\/mbio.02032-23","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"mBio"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0380-x","article-title":"The gut microbiome regulates the increases in depressive-type behaviors and in inflammatory processes in the ventral hippocampus of stress vulnerable rats","volume":"25","author":"Pearson-Leary","year":"2020","journal-title":"Mol Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00890-0","article-title":"Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis","volume":"21","author":"Aburto","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711891105","article-title":"Nicoli JR et\u00a0al: Commensal microbiota is fundamental for the development of inflammatory pain","volume":"105","author":"Amaral","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00677-w","article-title":"Role of the gut-brain axis in energy and glucose metabolism","volume":"54","author":"Wachsmuth","year":"2022","journal-title":"Exp Mol Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cells11060971","article-title":"Microbiota and pain: save your gut feeling","volume":"11","author":"Morreale","year":"2022","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105840","DOI":"10.1016\/j.phrs.2021.105840","article-title":"Wla\u017a P: The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"102029","DOI":"10.1016\/j.molmet.2024.102029","article-title":"The role of intestinal microbiota in physiologic and body compositional changes that accompany CLA-mediated weight loss in obese mice","volume":"89","author":"Zhang","year":"2024","journal-title":"Mol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ner.12908","article-title":"Dorsal root ganglion stimulation in experimental painful diabetic peripheral neuropathy: burst vs","volume":"22","author":"Franken","year":"2019","journal-title":"Conventional Stimul Paradigm Neuromodulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12020-019-01880-6","article-title":"Li J et\u00a0al: Mechanism of the JAK2\/STAT3-CAV-1-NR2B signaling pathway in painful diabetic neuropathy","volume":"64","author":"Li","year":"2019","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ner.13070","article-title":"Nonlinear relation between burst dorsal root ganglion stimulation amplitude and behavioral outcome in an experimental model of painful diabetic peripheral neuropathy","volume":"23","author":"Franken","year":"2020","journal-title":"Neuromodulation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.02.009","article-title":"Estimating efficacy and drug ED50\u2019s using von Frey thresholds: impact of weber\u2019s law and log transformation","volume":"13","author":"Mills","year":"2012","journal-title":"J Pain"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00991-z","article-title":"Bro\u017cy\u0144ska M, Zhu Q et\u00a0al: Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort","volume":"54","author":"Qin","year":"2022","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1413218","article-title":"Cui GY et\u00a0al: Pain, obesity, adenosine salvage disruption, and smoking behavior mediate the effect of gut microbiota on sleep disorders: results from network Mendelian randomization and 16S rDNA sequencing","volume":"15","author":"Li","year":"2024","journal-title":"Front Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/nu14010166","article-title":"Gut microbiota and complications of type-2 diabetes","volume":"14","author":"Iatcu","year":"2021","journal-title":"Nutrients"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02640-2","article-title":"Integrated analysis of gut microbiota, fecal and serum metabolites in type 2 diabetes mellitus with peripheral neuropathy","author":"Xu","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12866-025-04015-2","article-title":"Changes of intestinal microbiome and its relationship with painful diabetic neuropathy in rats","volume":"25","author":"Jia","year":"2025","journal-title":"BMC Microbiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"892","DOI":"10.2174\/1570159X14666160404124127","article-title":"Mechanisms by which stress affects the experimental and clinical inflammatory bowel disease (IBD): role of brain-gut axis","volume":"14","author":"Brzozowski","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/nu16050660","article-title":"Exploring the dynamic relationship between the gut microbiome and body composition across the human lifespan: A systematic review","volume":"16","author":"Komodromou","year":"2024","journal-title":"Nutrients"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"B39","doi-asserted-by":"publisher","first-page":"300060520936806","DOI":"10.1177\/0300060520936806","article-title":"Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes","volume":"48","author":"Wang","year":"2020","journal-title":"J Int Med Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01447-x","article-title":"Diabetic neuropathy: understanding the nexus of diabetic neuropathy, gut dysbiosis and cognitive impairment","volume":"23","author":"Babu","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.355769","article-title":"Jiang JH et\u00a0al: Alterations in gut microbiota are related to metabolite profiles in spinal cord injury","volume":"18","author":"Kang","year":"2023","journal-title":"Neural Regener Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051474","article-title":"The firmicutes\/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1632406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:17:46Z","timestamp":1758773866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1632406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":43,"alternative-id":["10.3389\/fendo.2025.1632406"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1632406","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1632406.s001","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"1632406"}}